Lincoln Pharmaceuticals Ltd

NSE: LINCOLN · BSE: 531633 · Pharmaceuticals & Biotechnology · 15 announcements

Share price: ₹563.85
Market cap: ₹1,129 Cr
Revenue (annual): ₹671.0 Cr
Net profit (annual): ₹87.89 Cr
P/E (TTM): 11.7×Sector 47.3×
Promoter holding: 49.78%+0.00% QoQ
FII holding: 4.60%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Board Meeting Date 2 Results Correction 1 Management Change 1 Dividend 1 Debt & Borrowing 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

16 Apr 2026 14:25 IST BSE

Debt & Borrowing

Lincoln Pharmaceuticals Debt & Borrowing

Lincoln Pharmaceuticals Ltd submitted its initial disclosure for FY 2026-27, confirming it does not fall under the Large Corporate category as of March 31, 2026. The company reported no outstanding borrowings under the framework's criteria. This routine regulatory filing follows SEBI's debt market borrowing requirements for listed entities.

Read the filing ↗